Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Caenorhabditis elegans pathways that surveil and defend mitochondria

Nature volume 508, pages 406–410 (2014)Cite this article

Subjects

Abstract

Mitochondrial function is challenged by toxic by-products of metabolism as well as by pathogen attack1,2. Caenorhabditis elegans normally responds to mitochondrial dysfunction with activation of mitochondrial-repair, drug-detoxification and pathogen-response pathways1,2,3,4,5,6,7. Here, from a genome-wide RNA interference (RNAi) screen, we identified 45 C. elegans genes that are required to upregulate detoxification, pathogen-response and mitochondrial-repair pathways after inhibition of mitochondrial function by drug-induced or genetic disruption. Animals defective in ceramide biosynthesis are deficient in mitochondrial surveillance, and addition of particular ceramides can rescue the surveillance defects. Ceramide can also rescue the mitochondrial surveillance defects of other gene inactivations, mapping these gene activities upstream of ceramide. Inhibition of the mevalonate pathway, either by RNAi or statin drugs, also disrupts mitochondrial surveillance. Growth of C. elegans with a significant fraction of bacterial species from their natural habitat causes mitochondrial dysfunction. Other bacterial species inhibit C. elegans defence responses to a mitochondrial toxin, revealing bacterial countermeasures to animal defence.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mitochondrial dysfunction activates homeostatic, detoxification and pathogen responses.
Figure 2: Some bacterial species from the C. elegans natural habitat antagonize the mitochondria.
Figure 3: The serine palmitoyltransferase sptl-1 is required for mitochondrial surveillance.
Figure 4: Ceramide biogenesis is required for mitochondrial surveillance.

References

  1. Melo, J. A. & Ruvkun, G. Inactivation of conserved C. elegans genes engages pathogen- and xenobiotic-associated defenses. Cell 149, 452–466 (2012)

    Article  CAS  Google Scholar 

  2. Runkel, E. D., Liu, S., Baumeister, R. & Schulze, E. Surveillance-activated defenses block the ROS-induced mitochondrial unfolded protein response. PLoS Genet. 9, e1003346 (2013)

    Article  CAS  Google Scholar 

  3. Benedetti, C., Haynes, C. M., Yang, Y., Harding, H. P. & Ron, D. Ubiquitin-like protein 5 positively regulates chaperone gene expression in the mitochondrial unfolded protein response. Genetics 174, 229–239 (2006)

    Article  CAS  Google Scholar 

  4. Haynes, C. M., Petrova, K., Benedetti, C., Yang, Y. & Ron, D. ClpP mediates activation of a mitochondrial unfolded protein response in C. elegans. Dev. Cell 13, 467–480 (2007)

    Article  CAS  Google Scholar 

  5. Haynes, C. M., Yang, Y., Blais, S. P., Neubert, T. A. & Ron, D. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans.. Mol. Cell 37, 529–540 (2010)

    Article  CAS  Google Scholar 

  6. Nargund, A. M., Pellegrino, M. W., Fiorese, C. J., Baker, B. M. & Haynes, C. M. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science 337, 587–590 (2012)

    Article  CAS  ADS  Google Scholar 

  7. Durieux, J., Wolff, S. & Dillin, A. The cell-non-autonomous nature of electron transport chain-mediated longevity. Cell 144, 79–91 (2011)

    Article  CAS  Google Scholar 

  8. Pellegrino, M. W., Nargund, A. M. & Haynes, C. M. Signaling the mitochondrial unfolded protein response. Biochim. Biophys. Acta 1833, 410–416 (2013)

    Article  CAS  Google Scholar 

  9. Estes, K. A., Dunbar, T. L., Powell, J. R., Ausubel, F. M. & Troemel, E. R. bZIP transcription factor zip-2 mediates an early response to Pseudomonas aeruginosa infection in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 107, 2153–2158 (2010)

    Article  CAS  ADS  Google Scholar 

  10. Félix, M. A. & Duveau, F. Population dynamics and habitat sharing of natural populations of Caenorhabditis elegans and C. briggsae. BMC Biol. 10, 59 (2012)

    Article  Google Scholar 

  11. Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet. 33, 40–48 (2003)

    Article  CAS  Google Scholar 

  12. Menuz, V. et al. Protection of C. elegans from anoxia by HYL-2 ceramide synthase. Science 324, 381–384 (2009)

    Article  CAS  ADS  Google Scholar 

  13. Deng, X. et al. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of C. elegans. Science 322, 110–115 (2008)

    Article  CAS  ADS  Google Scholar 

  14. Sentelle, R. D. et al. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nature Chem. Biol. 8, 831–838 (2012)

    Article  CAS  Google Scholar 

  15. Colombini, M. Ceramide channels and their role in mitochondria-mediated apoptosis. Biochim. Biophys. Acta 1797, 1239–1244 (2010)

    Article  CAS  Google Scholar 

  16. Wenner Moyer, M. The search beyond statins. Nature Med. 16, 150–153 (2010)

    Article  CAS  Google Scholar 

  17. Graham, D. J. et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. J. Am. Med. Assoc. 292, 2585–2590 (2004)

    Article  CAS  Google Scholar 

  18. Rauthan, M., Ranji, P., Aguilera Pradenas, N., Pitot, C. & Pilon, M. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway. Proc. Natl Acad. Sci. USA 110, 5981–5986 (2013)

    Article  CAS  ADS  Google Scholar 

  19. Hage-Sleiman, R., Esmerian, M. O., Kobeissy, H. & Dbaibo, G. p53 and ceramide as collaborators in the stress response. Int. J. Mol. Sci. 14, 4982–5012 (2013)

    Article  CAS  Google Scholar 

  20. Senkal, C. E. et al. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network. J. Biol. Chem. 286, 42446–42458 (2011)

    Article  CAS  Google Scholar 

  21. Breslow, D. K. & Weissman, J. S. Membranes in balance: mechanisms of sphingolipid homeostasis. Mol. Cell 40, 267–279 (2010)

    Article  CAS  Google Scholar 

  22. Bookout, A. L. & Mangelsdorf, D. J. Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways. Nucl. Recept. Signal. 1, e012 (2003)

    Article  Google Scholar 

  23. Phillips, C. M., McDonald, K. L. & Dernburg, A. F. Cytological analysis of meiosis in Caenorhabditis elegans. Methods Mol. Biol. 558, 171–195 (2009)

    Article  CAS  Google Scholar 

  24. Wagner, B. K. et al. A small-molecule screening strategy to identify suppressors of statin myopathy. ACS Chem. Biol. 6, 900–904 (2011)

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank C. Haynes (Memorial Sloan Kettering Cancer Center), F. Ausubel (Massachusetts General Hospital) and the Caenorhabditis Genetics Center for providing strains; and the V. Mootha laboratory (Massachusetts General Hospital) for providing C2C12 cells. We thank J. Larkins-Ford, C. Phillips, S. Garcia and M. Pellegrino for technical support, as well as M. A. Félix for bacterial strains and for guidance in the collection of microbial strains from C. elegans natural habitats. Y.L. is supported by the Helen Hay Whitney research fellowship; B.S.S. is supported by the Charles King Trust postdoctoral fellowship. The work is supported by a grant from the National Institutes of Health, awarded to G.R. (NIH AG043184-16).

Author information

Author notes

  1. Ying Liu

    Present address: Present address: State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Molecular Medicine, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100871, China.,

Authors and Affiliations

  1. Department of Molecular Biology, Massachusetts General Hospital, Boston, 02114, Massachusetts, USA

    Ying Liu, Buck S. Samuel, Peter C. Breen & Gary Ruvkun

  2. Department of Genetics, Harvard Medical School, Boston, 02115, Massachusetts, USA

    Ying Liu, Buck S. Samuel, Peter C. Breen & Gary Ruvkun

Authors
  1. Ying Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Buck S. Samuel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter C. Breen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gary Ruvkun
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Y.L. and G.R. designed experiments; Y.L., B.S.S. and P.C.B. carried out experiments. Y.L., B.S.S. and G.R. wrote the paper. G.R. supervised the project.

Corresponding author

Correspondence to Gary Ruvkun.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Extended data figures and tables

Extended Data Figure 1 Mitochondrial dysfunction activates homeostatic, detoxification and pathogen responses.

a, Drug-induced food-avoidance phenotypes on live or dead bacteria. Dead bacteria were obtained by heating bacteria at 90 °C for 30 min. Avoidance behaviour was also observed when antimycin was added to dead bacteria, showing that the drug acts directly on C. elegans and is not transformed by the bacteria. b, Quantification of the food-avoidance phenotypes of Extended Data Fig. 1a (n = 4). Error bars represent s.d. c, A dose response of hsp-6p::gfp induction with the addition of antimycin.

Extended Data Figure 2 Diagram of the genome-wide RNAi screen workflow.

For the detailed experimental procedure, see Methods.

Extended Data Figure 3 Diagram of the sphingolipid metabolism pathway and the corresponding genes.

Extended Data Figure 4 sptl-1 is required for mitochondrial surveillance.

a, A graph showing the fold change in C. elegans sptl-1 transcript level compared to control (n = 3). Error bars represent s.d. b, hsp-6p::gfp worms raised on control or sptl-1(RNAi) (n = 40). c, Body wall muscle animals expressing a mitochondrially localized GFP reporter. The animals were subjected to sptl-1(RNAi) for 36 h and transferred onto the second RNAi (control, fzo-1, fis-1 or drp-1). The hyperfusion of mitochondria observed under sptl-1(RNAi) is dependent on the fusion machinery as disruption of mitochondrial fusion by inactivating fzo-1 or fis-1 partially restored the tubular structure. By contrast, inhibition of the gene drp-1 that governs fission led to mitochondrial hyperfusion. The images were taken 36 h after they were placed on the second RNAi. d, A graph showing the percentage of worms which avoid the spg-7(RNAi) bacteria lawn 48 h after they were initially placed on the plates (n = 4). Error bars represent s.d. e, A graph showing the percentage of worms that avoid the bacteria lawn 8 h after the addition of antimycin (n = 4). Error bars represent s.d. f, Wild-type N2 or sptl-1(ok1693) mutant animals raised in the presence or absence of 0.8 μM antimycin. Photos were taken 4 days after the synchronized L1 worms were placed on the plates. g, hsp-6p::gfp animals were raised on sptl-1(RNAi) for 36 h and transferred onto a subset of wild microbes. The images were taken after 2 days.

Extended Data Figure 5 Ceramide biosynthesis is required for mitochondrial surveillance.

a, Genotyping of the sphingolipid metabolism pathway mutant alleles. b, c, Fold difference in hsp-6 transcript levels in wild type or sphingolipid metabolism pathway mutants (b) and hyl-1 or lagr-1 mutants (c) (n = 3). Error bars represent s.d. d, hsp-6p::gfp worms raised on sptl-1(RNAi) in the presence of increasing amounts of ceramide. e, hsp-6p::gfp in the presence or absence of ceramide.

Extended Data Figure 6 Ceramide biogenesis is required for mitochondrial surveillance.

a, The percentage of worms that avoid the bacterial lawn 8 h after the addition of antimycin. Animals were pre-treated with control RNAi, control RNAi with ceramide, sptl-1(RNAi) or sptl-1(RNAi) with ceramide (n = 4). Error bars represent s.d. b, Time course experiment for the induction of hsp-6p::gfp with antimycin. c, Dissected young adults after 4 h antimycin treatment were stained with anti-COX-IV antibody (green) and anti-ceramide antibody (red). d, Nomarski (top) and fluorescent (bottom) images of intestinal cells in atfs-1;hsp-16p::atfs-1Δ1-32.myc::gfp transgenic animals. e, hsp-6p::gfp worms raised on indicated RNAi in the presence or absence of ceramide.

Extended Data Figure 7 Inhibition of the mevalonate pathway disrupts mitochondrial surveillance.

a, hsp-6p::gfp animals raised on control or hmgs-1(RNAi) in the presence of antimycin. b, Immunoblotting of GFP expressed by hsp-6p::gfp animals, with or without antimycin. c, Antimycin-induced food avoidance in control or hmgs-1(RNAi) animals. d, Quantification of food avoidance (n = 4). Error bars represent s.d. e, Body wall muscle of control or hmgs-1(RNAi) animals expressing a mitochondrially localized GFP reporter. f, hsp-6p::gfp animals raised on hmgs-1(RNAi), or hmgs-1(RNAi) with addition of mevalonate exposed to antimycin. g, hsp-6p::gfp animals treated with antimycin after pre-treatment with simvastatin or mevastatin. h, Mitochondrial immunostaining in HEK293T cells. i, ATP levels in C2C12 myotubes after treating with simvastatin or mevastatin (n = 3). Error bars represent s.d.

Extended Data Figure 8 Statin treatment impairs mitochondrial surveillance.

a, Diagram of the mevalonate pathway for the biosynthesis of cholesterol, ubiquinone and haem A, and protein N-glycosylation and prenylation. b, hsp-6p::gfp animals treated with antimycin after pre-treatment with increasing concentration of simvastatin. c, hsp-6p::gfp animals with mock, 80 μg ml−1 simvastatin or 80 μg ml−1 mevastatin treatment. d, hsp-6p::gfp animals raised on control RNAi, hmgs-1(RNAi), or hmgs-1(RNAi) with the addition of geranylgeranyl pyrophosphate. The animals were then treated with antimycin to induce mitochondrial damage. Statin toxicity has been proposed to be caused by the inhibition of Rab prenylation24. Geranylgeranyl pyrophosphate (GGPP), a precursor of protein prenylation rescued the statin side effect in cell culture24. GGPP also partially rescued the deficiency of mitochondrial surveillance and activated hsp-6p::gfp in antimycin-treated hmgs-1(RNAi) animals.

Extended Data Figure 9 Mitochondrial immunostaining in HEK293T cells.

The cells were treated with DMSO, 10 μM simvastatin or 10 μM mevastatin for 2 days.

Extended Data Table 1 Full list of genes identified in the genome-wide RNAi screen for mitochondrial surveillance
Full size table

Supplementary information

Movement abilities of animals treated with control RNAi

Animals were filmed after 48 hours of growth on control RNAi. (MOV 1725 kb)

Movement abilities of animals treated with sptl-1(RNAi)

Animals were filmed after 48 hours of growth on sptl-1(RNAi) (MOV 2107 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liu, Y., Samuel, B., Breen, P. et al. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 508, 406–410 (2014). https://doi.org/10.1038/nature13204

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nature13204

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing